Polymorphisms of the peroxisome proliferator-activated receptor-γ and its coactivator-1α genes in Chinese women with polycystic ovary syndrome

Fertility and Sterility

Volumn 85, Issue 5, 2006, Pages 1536-1540

  Wang, Yong ^a,b   Wu, XiaoKe ^b   Cao, Yunxia ^c   Yi, Long ^a   Fan, Haijian ^a   Chen, Jianxiu ^a  

^a NANJING UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEAT-SHOCK PROTEINS; HUMANS; INCIDENCE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK ASSESSMENT; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 33646082751     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.10.047     Document Type: Article

References (25)

1. Su Y. Polycystic ovary syndrome. In: Zhang L. (Ed). Clinical reproductive endocrinology and infertility (2001), Chinese Scientific Publishing Company, Beijing 367-399
2. Spiegelman B.M. PPAR-gamma. adipogenic regulator and thiazolidinedione receptor. Diabetes 47 (1998) 507-514
3. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351 (2004) 1106-1118
4. Deeb S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 (1998) 284-287
5. Jacob S., Stumvoll M., Becker R., Koch M., Nielsen M., Loblein K., et al. The PPARγ2 polymorphism Pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm Metab Res 32 (2000) 413-416
6. Hara M., Alcoser S.Y., Qaadir A., Beiswenger K.K., Cox N.J., and Ehrmann D.A. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPARγ gene. J Clin Endocrinol Metab 87 (2002) 772-775
7. Korhonen S., Heinonen S., Hiltunen M., Helisalmi S., Hippelainen M., Koivunen R., et al. Polymorphism in the peroxisome proliferator acticated receptor-α gene in women with polycystic ovary syndrome. Hum Reprod 18 (2003) 540-543
8. Orio Jr. F., Matarese G., Di Biase S., Palomba S., Labella D., Sanna V., et al. Exon 6 and 2 peroxisome proliferator-activated receptor-α polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 5887-5892
9. Orio Jr. F., Palomba S., Cascella T., Di Biase S., Labella D., Russo T., et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 5110-5115
10. Tok E.C., Aktas A., Ertunc D., Erdal E.M., and Dilek S. Evaluation of glucose metabolism and reproductive hormones in polycystic of ovary syndrome on the basis of peroxisome proliferator activated receptor (PPAR)-γ2 Pro12Ala genotype. Hum Reprod 20 (2005) 1590-1595
11. Hahn S., Fingerhut A., Khomtsiv U., Khomtsiv L., Tan S., Quadbeck B., et al. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 62 (2005) 573-579
12. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1alpha). transcriptional coactivator and metabolic regulator. Endocr Rev 24 (2003) 78-90
13. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998) 829-839
14. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999) 115-124
15. Ek J., Andersen G., Urhammer S.A., Gaede P.H., Drivsholm T., Borch-Johnsen K., et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44 (2001) 2220-2226
16. Hara K., Tobe K., Okada T., Kadowaki H., Akanuma Y., Ito C., et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45 (2002) 740-743
17. Chen S., Yan W., Huang J., Yang W., and Gu D. Peroxisome proliferator-activated receptor-γ coactivator-1α polymorphism is not associated with essential hypertension and type 2 diabetes mellitus in Chinese population. Hypertens Res 27 (2004) 813-820
18. Lacquemant C., Chikri M., Boutin P., Samson C., and Froguel P. No association between the G482S polymorphism of the proliferator-activated receptor coactivator-1 (PGC-1) gene and type II diabetes in French caucasians. Diabetologia 45 (2002) 602-603
19. Oberkofler H., Holzl B., Esterbauer H., Xie M., Iglseder B., Krempler F., et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus. associations with hypertension in middle-aged men. Hypertension 41 (2003) 368-372
20. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
21. Andrulionyte L., Zacharova J., Chiasson J.L., and Laakso M. Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47 (2004) 2176-2184
22. Mori Y., Kim-Motoyama H., Katakura T., Yasuda K., Kadowaki H., Beamer B.A., et al. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor-γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 251 (1998) 195-198
23. Dunaif A. Insulin resistance and the polycystic ovary syndrome. mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774-800
24. Dunaif A., Wu X., Lee A., and DiamantiKandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281 (2001) E392-E399
25. Li M., Youngren J.F., Dunaif A., Goldfine I.D., Maddux B.A., Zhang B.B., et al. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS. effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 87 (2002) 4088-4093